PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,676 | +814.4% | 138,200 | +564.4% | 0.01% | +400.0% |
| Q4 2022 | $402 | -100.0% | 20,800 | -77.9% | 0.00% | -66.7% |
| Q3 2022 | $1,970,000 | +134.0% | 94,300 | -10.3% | 0.00% | +200.0% |
| Q2 2022 | $842,000 | +13.8% | 105,100 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $740,000 | +80.9% | 105,600 | +248.4% | 0.00% | 0.0% |
| Q4 2021 | $409,000 | -19.2% | 30,307 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $506,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |